NASDAQ · Shell Companies · USD

Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Analysis

Oaktree Acquisition Corp. III Life Sciences (OACC) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

OACC

$10.69

+$0.03 (+0.28%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare OACC with… →

OACC Key Statistics

As of Oct 21, 2026

Trading

Open: $10.67
Previous Close: $10.66
Day's Range: 10.66–10.69
52-Week Range: 10.50–10.93
Volume: 14.64K

Valuation

Market Cap: $262.79M
P/E Ratio: 38.18
EPS (ttm): 0.28

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): $7.29M
Shares Outstanding: 19.78M
1-Year Return: +1.81%

Dividend and dates

Avg Volume: 36.28K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, OACC closed at $10.69, +1.81% over 1 year.

Oaktree Acquisition Corp. III Life Sciences (OACC) has a market capitalization of $262.79M.

OACC Stock Return by Calendar Year

Oaktree Acquisition Corp. III Life Sciences (OACC) return since Dec 2024: what $10,000 became

1 year: $10,000 $10,181; +1.81%
Since Dec 2024: $10,000 $10,690; +6.90%

If you had invested $10,000 in Oaktree Acquisition Corp. III Life Sciences (OACC) at the close on December 16, 2024, the earliest close on record here, it would have been worth $10,690 at the close on October 21, 2026: +6.90% in total, +3.68% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−0.40%+6.22%+1.04%

2024*20252026*

Year	Return
2026 (partial year)	+1.04%
2025	+6.22%
2024 (partial year)	−0.40%

As of October 21, 2026.

OACC Valuation vs Shell Companies Median

Median of 309 stocks

Metric	OACC	Shell Companies median	vs median
P/E	38.18	49.16	22% below

Medians across 309 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

Oaktree Acquisition Corp. III Life Sciences (OACC) carries a market capitalisation of $262.79M. It is classified in the Shell Companies industry, within the Financial Services sector.

OACC last closed at $10.69 on October 21, 2026. That is +$0.03 (+0.28%) against the previous close. The 52-week range on file runs from $10.50 to $10.93. The latest close sits 1.81% above that 52-week low.

Financial Health

In fiscal 2025, Oaktree Acquisition Corp. III Life Sciences reported revenue of $0.00. The same year closed with net income of $7.29M. Trailing earnings per share are 0.28.

Valuation Assessment

OACC trades at a trailing price-to-earnings ratio of 38.18. That is 22.33% below the Shell Companies median of 49.16. 309 Shell Companies companies report these metrics, and the medians quoted come from that group.

Daily returns over the trailing 1 year annualize to a volatility of 5.14%. The trailing one-year total return is +1.81%. The stored price history starts on December 16, 2024, and the total return since then is +6.90%.

Growth & Income

No dividend is on file for OACC.

The record holds one complete calendar year, 2025, which returned +6.22%. 2026 is still running; the total return is +1.04% year to date.

Peer Comparison

Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Oaktree Acquisition Corp. III Life Sciences	OACC	$262.79M	38.2
Vylor Inc.	VYLR	$49.89B	106.8
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

The Shell Companies industry average P/E ratio is 49.2x. Oaktree Acquisition Corp. III Life Sciences trades at a P/E of 38.2.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$49.89B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

BCSS

Bain Capital GSS Investment Corp.

$596.26M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Visit website →